Covax vaccine has provided surgery by the end of 2021, with a record of 300 million doses sent in December.
The Covax Facility released an over 309 million dose of coronavirus vaccine in December, indicating a significant increase in the global vaccine distribution that suffered the most in 2021 due to the scarcity of resources and complexity.
In all, about 910 million donations were made through a UN-funded program since December 30, according to a UNICEF interim report published in The Washington Post on Friday.
Subscribe to the Greatest News Release from the Washington Post.
The final figure for the year is about to reach the 2 billion additional level Covax originally wanted, and it is the players who are under the high goals that some freedom fighters have said they should expect. But with about one-third of the dose given in the last month of the year, there is hope that Covax will be able to stop the problems that plagued it in 2020.
“It brings tears to my eyes,” said Olly Cann, director of communications at Gavi, a vaccine, nonprofit organization that is one of the three sponsors of the program, along with the World Health Organization and Coalition for Epidemic Preparedness. New.
This is especially true after a difficult year in the campaign to share the vaccine, which was strongly criticized between the missed dates and the modified goals. Lawrence Gostin, director of the O’Neill Institute for National and Global Health Law at Georgetown University, said “there is no doubt that Covax has been frustrated and failed to do well.”
But Gostin said the increase in Covax is a sign of change in vaccine use worldwide. “We are coming to a country where availability is not a big problem like just vaccinating and taking them into the hands of the people,” he said.
While it is unclear whether the increase in donations will continue in 2022, Covax officials said the rapid pace of growth was due to a number of positive factors, including quantities.
One of the major issues is the increase in information from providers over the time the dosage is available, Cann said, which allowed the recipient countries to better plan for distribution and delivery, as most of the given rates have a longer duration. “We don’t want to give it to countries that can’t afford the dosage,” Cann said.
More than 70 countries received doses through Covax in December, from Bangladesh, which received more than 76 million, to Barbados, which received 14,040.
Other major recipients are Indonesia, Philippines and Pakistan, who received at least 25 million in December.
More than half of the global dose released last month of the year came from three US-sponsored vaccine manufacturers: Johnson & Johnson, Moderna and Pfizer-BioNTech.
Covax was formed in the early days of the epidemic, with the official announcement of its launch in April 2020. Its aim was to ensure that low- and low-income countries could receive the Standard by asking states to use their resources to build. a history of Doses that can be shared equally.
But this was difficult to raise funds in 2020 and fell behind the world’s governments by calling for standards and vaccinators.
It continued in April, when the Indian government began banning the shipment of locally made vaccines amidst coronavirus cases related to delta diversity. The move cut Covax from a major contributor, the Serum Institute of India, which is expected to provide more than 1 billion vaccines approved by Oxford University-AstraZeneca.
India resumed exports in November, with the level of vaccines purchased from Chinese manufacturers Sinopharm and Sinovac set to be exported in August.
The largest dose increase, however, came after the United States, the European Union and other rich countries began offering Coverage through Covax over the summer. Numerous dosages from Johnson & Johnson, Moderna and Pfizer-BioNTech have been issued, which has raised concerns that the dosage process could worsen if donor countries feel threatened by omicron or other species.
At a press conference last week, WHO chief Tedros Adhanom Ghebreyesus spoke of the prospect of a vaccine in 2022, but added that warnings in many rich countries could promote global inequality.
“Our goals show that access should be enough to vaccinate all adults around the world and empower vulnerable people, by the first quarter of 2022,” Tedros said on December 22. to be able to make the most of the incentives for all adults. “
Related
This price has been here for 500 years. Will it sell for $ 17,500?
Source link
